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ABSTRACT
Peritoneal dialysis (PD) using an ordinary stylet cannula was studied in 253 patients (67% male and 33% female
with age ranging from 3-67 years) suffering from renal failure. The study was conducted between January 2007
and December 2012. The procedure was well tolerated by the patients. The desired aims of dialysis including
improvement in chemistry were achieved in all surviving (94.5%) cases. Mortality during PD was 5.5% and was
related to the underlying causes of renal failure. Peritonitis seen in 30% cases was the commonest complication.
Other complications in order of frequency were, hypokalemia (8%), severe hyperglycemia in diabetic patients
(6%), and sever hypovolemia (5%), pericatheter leak (5%) and catheter blockage (2%). Perforation of the bowel, a
serious  complication  occurring  during  insertion  of  the  PD  cannula  was  not  seen  in  any  of  the  cases.  It  is
concluded from the study that PD is a simple and cost effective alternative to hemodialysis and have special
advantages  in the current  set-up  of  the  institute. The  objective  of  our  work  was  to  study  the  results  and
complications of peritoneal dialysis in light of its efficacy as an alternative form of renal replacement therapy
(RRT) to hemodialysis.
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INTRODUCTION
Renal replacement  therapy  (RRT)  in  the  form  of
dialysis (hemodialysis/  peritoneal  dialysis) or
transplantation remains the sole treatment for patients
who sustain renal failure. The gold standard for renal
failure  (End  stage  renal  disease-ESRD)  is
transplantation but unfortunately it  is  restricted  by
financial  limitations in  developing  countries  like
Pakistan.
1 Similarly the hemodialysis (HD) facilities
are  scarce  due  to  the  lack  of  necessary  funds.  At
present there are only 175 dialysis centers throughout
the country
2 and few of them are available in remote
areas. The dialysis treatment is in-fact expensive and
at  the  same  time lifesaving  but  due  to  meager
facilities and poverty, the PD is a cheaper option in
CKD patients with good residual renal function.
Renal  failure  is  becoming  a  public  health  problem
with increasing incidence and prevalence, high cost
and unfortunately poor outcome.
3The total burden of
ESRD continues to rise including patients with many
advanced comorbidities.
4The growing burden of this
special population requires the use of alternative renal
replacement  therapy. Peritoneal  dialysis  (PD) is  an
alternative renal  supportive  therapy  (RST) to  HD
which if use wisely can share some of the load. The
utilization  of  peritoneal dialysis is low despite of
equal patient survival on HD and PD, and fluctuates
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only at around 15% of the ESRD population.
5,6 Both
PD  and  HD  have  their  specific  advantages  and
disadvantages  and  different  factors influence  the
choice of RRT. PD is generally preferred to HD in
very  small  children  and  those  with severe
cardiovascular instability.
7,8
The  better  preservation  of  residual  renal  function,
lower risk of infections with hepatitis B and C, better
outcome  after  transplantation,  preservation  of
vascular  access  and  lower  cost  are  arguments  to
promote  PD  as  a good  initial  treatment. Hospital
based PD  may  be  the  only  option  for  elderly  with
significant  morbidities making  them  unable  to
undergo HD. Despite a valuable and effective option
with acceptable survival rates the use of PD is still
low for special group of ESRD.
6,9
There have been very few publications on the clinical
experience  of PD  in  our country; this  study  was
therefore  conducted  with  the  aim  to  describe our
experience and results of PD at our institute.
MATERIAL AND METHODS
Sample size  and  study location: This study  was
conducted at the department of Nephrology, Institute
of Kidney  Diseases,  HMC,  Peshawar  between  Jan
2007 and December 2012 after taking approval from
the ethics committee of our institution. A total of 253
patients who presented with end stage renal disease
(ESRD) / Acute Renal Failure (ARF) were recruited
from January 2007 to December 2012 (6 years).
Study subjects
Inclusion  criteria: Subjects  from  all  age  groups,
including  paediatric  population  (less  than  8  years
old), patients with poor cardiovascular status (blood
pressure less than 100 systolic, evidence of previous
myocardial  infarction  or  cerebrovascular  accident)
and those with hepatitis B surface antigen were given
PD instead of HD. Patents from far flung areas were
given palliative PD if it was felt that their prospects
of  long  term  dialysis  or  transplant  were  extremely
poor.  Lack  of  HD  slot  or  unavailability  of
consumables in the HD unit as well as refusal for HD
by the patients or their relative were another reason
for  choosing  PD. Verbal  and  written  informed
consent  was  obtained  from  the  participants  of  the
study.
Exclusion  criteria: Patients,  who  were
hemodynamically stable, had prospects for long term
maintenance hemodialysis and had prospects for renal
transplantation. Those  patients  who  had  access  and
affordability for dialysis were excluded from the PD
group.  Age  group  more  than  10  years  with
hemodynamic stability was also not included in the
PD group.
Peritoneal Dialysis  Procedure: Following  urinary
catheterization, PD cannula insertion was performed
as  a  bedside  procedure  in  the  ward  using  aseptic
techniques  and  local  anesthesia.  In  order  to  avoid
perforation  of  the  bowl  and  facilitate  optimum
positioning  of  the  PD  catheter,  intraperitoneal
infusion of about two liter dialysate using an ordinary
intravenous cannula was usually carried out prior to
insertion of the PD cannula. The cannula was secured
and the entry point was closed by applying a purse-
string suture. Hourly exchanges with 500 ml to 2000
ml  standard  PD  solution  (Braun  or  Otsuka)  were
carried out. Two hundred units of heparin were added
to each liter of dialysate. Proper record of exchange
with emphasis on accurate fluid balance was kept.
Clinical and Biochemical assessment: Patients were
assessed  clinically  and  pre- and  post-dialysis
chemistry was measured to look at the efficacy of the
dialysis.
Statistical analysis: All the results were expressed as
percentages and frequencies by using Microsoft Excel
(version 2010).
RESULTS
Gender based distribution of patients with renal
failure
The data in table 1 show gender based distribution of
patients with renal failure. It is clear from the table
that among 253 patients 170 were male and 83 were
female. The mean age of patients was 23 years ranged
between 3 to 67 years.
Table  1:  Gender  based  distribution  of  patients
with renal failure
Gender Number Percentage
Male 170 67
Female 83 33
Causes of chronic renal failure (CRF)
The  data  in  table  2  shows  the  various  causes  of
chronic  renal  failure.  Out  of  253  cases  152  (60%)
were  suffering  from  chronic  renal  failure.  Most  of
these  patients  had  small  echogenic  kidneys  (n=93)
suggesting  the  underlying  causes  of
glomerulonephritis  in the  majority  followed  by7
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diabetic  nephropathy  (n=18). The  adult  polycystic
kidney  disease was  found  in  16  cases  followed  by
obstructive uropathy (n=14). Renal amyloidosis and
cirrhosis was found in 6 and 5 cases, respectively.
Table  2:  Causes  of  chronic renal  failure  (CRF)
(n=152)
Causes of CRF Number %
Small  echogenic  kidneys
(chronic glomerulonephritis)
93 61.18
Diabetic nephropathy 18 11.84
Adult  polycystic  kidney
disease
16 10.53
Obstructive uropathy 14 9.21
Renal amyloidosis 6 3.95
Cirrhosis 5 3.29
Causes of acute renal failure (ARF)
40% (101) of the patients had ARF. Table 3 shows
the  causes  of  ARF  from  various  causes.. The
commonest cause of ARF was post-diarrheal volume
depletion  (n=24)  followed  by  hemolytic  uremic
syndrome  (n=15),  obstetrics  (n=13)  and  septicemia
(n=12).  Other  factors  responsible  included
obstruction  from  calculi  (n=11),  acute
glomerulonephritis  (n=7),  acute  tublo-interstitial
nephritis (n=5), acute pyelonephritis (n=5), hemolysis
(n=3),  post-operative  (post-CABG)  (n=3),  and
poisoning (n=3), respectively.
Table  3:  Causes  of  acute  renal  failure  (ARF)
(n=101)
Causes of ARF Number %
Post-diarrheal volume depletion 24 23.76
Hemolytic uremic syndrome 15 14.85
Obstetric 13 12.87
Septicemia 12 11.88
Obstruction from calculi 11 10.89
Acute glomerulonephritis 7 6.93
Acute tublo-interstitial nephritis 5 4.95
Acute Pyelonephritis 5 4.95
Hemolysis 3 2.97
Post-operative (post-CABG) 3 2.97
Poisoning 3 2.97
Reasons for choosing peritoneal dialysis
Reasons for choosing PD dialysis as an alternative to
HD included; very small children (22.13%), HbsAg
positive  (11.86%),  lack  of  HD  slot  (33.99%),
palliative PD for CRF (33.99%) and cardiovascular
instability (20.95%).
Table 4: Reasons for choosing peritoneal dialysis
Reasons for choosing PD Number Percentage
Small children 56 22.13
HbsAg +ve 30 11.86
Lack of HD slot 86 33.99
Palliative care for CRF 86 33.99
Cardiovascular instability 53 20.95
Hepatitis B surface antigen status of the patients
given peritoneal dialysis
Thirteen  patients  in  the  ARF  group  and  twenty
patients  in  the  CRF  group  had  hepatitis  B  surface
antigen positive (Table 5). Infection with hepatitis B
may be associated with a variety of renal diseases i.e.
membranous  glomerulonephritis,  membrane
proliferative  glomerulonephritis,  IgA  nephropathy,
mesangial  glomerulonephritis  and  amyloidosis
etc.
23,24
Table 5: Hepatitis B surface antigen of the patients
given peritoneal dialysis
HbsAg(+ve) HbsAg(-ve) Total
ARF 13 88 101
CRF 23 129 152
Total 36 216 253
(ARF: Acute renal failure, CRF: Chronic renal failure)
Effect of peritoneal dialysis on the blood chemistry
of the patients
There  was  an  overall  improvement  in  the  blood
chemistry of the patients. The peritoneal clearance of
blood  urea  and  serum  creatinine  before  and  after
dialysis in both ARF and CRF patients is presented in
table 6.
Table.6 Effect of peritoneal dialysis on the blood
chemistry of the patients
Blood urea
(mg/dl)
S. Creatinine
(mg/dl)
Pre-dialysis in ARF 170-400
(mean 190)
8-18
(mean 12)
Post-dialysis in ARF 50-110
(mean 64)
1.2-3.5
(mean 1.4)
Pre-dialysis in CRF 280-324
(mean 300)
13-25
(mean 15)
Post-dialysis in CRF 100-150
(mean 120)
4-6
(mean 5.0)
(ARF: Acute renal failure, CRF: Chronic renal failure)8
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Complications during peritoneal dialysis
Various complications during peritoneal dialysis were
also  experienced  (Table  7).  The  most  common
complication  was  peritonitis  which  occurred  in  76
(30%) cases, which responded to antibiotic therapy
and  removal  of  the  PD  cannula.  Traumatic
complications from insertion of the PD cannula were
infrequent  and  were  mainly  minor  intra-peritoneal
bleed (n=15). None of the patient had perforation of
the  bowl.  Other  catheter  related  complications
included  pericatheter  leak (n=13).  Scrotal  edema
(n=10), pain on running fluid (n=8) and blockage of
catheter (n=5), the later responding to repositioning
of the catheter. Metabolic complications encountered
were hypokalemia in 20 cases, severe hyperglycemia
in  15  diabetic  patients  and  severe  hypovolemia
requiring intravenous fluids in 13 cases.
Table.7 Complications during peritoneal dialysis
Complications Number %
PD peritonitis 76 30.04
Blood stained effluent 15 5.93
Pericatheter leak 13 5.14
Scrotal edema 10 3.95
Pain on running fluid 8 3.16
Blockage  of  catheter
(catheter repositioned)
5 1.98
Hypokalemia 20 7.91
Hyperglycemia
(in diabetes)
15 5.93
Hypovolemia 13 5.14
Signs and symptoms of peritonitis
Signs  and  symptoms  of  peritonitis  in  order  of
frequency were abdominal pain (98%), fever (77%),
rigors  (33%),  diarrhea  (17%),  nausea  and  vomiting
(13%) and constipation (10%).
Table 8: Signs and symptoms of peritonitis (n=76)
Symptoms and signs Number %
Abdominal pain 75 98
Fever 59 77
Rigors 25 33
Diarrhea 13 17
Nausea and vomiting 10 13
Constipation 8 10
Abdominal tenderness 64 84
Leukocytosis 56 74
Cloudy fluid 76 100
Most  patients  with  peritonitis  had  pyrexia  (77%),
abdominal tenderness (84%) and leukocytosis (74%).
All  (100%)  patients  suffering  from  peritonitis  had
cloudy  fluid  on  return.  Multiple  other  studies  have
also observed that more than 90% of the patients have
cloudy  fluid  (100%  of  ours)  and  many  have
abdominal pain (98% of our patients).
27,28
Frequency  of  organisms  isolated  from  patients
peritonitis
Table 9 shows the incidence of different organisms
responsible for peritonitis. Gram positive organisms
were responsible for 44 cases of peritonitis and were
either  due  to  Staph aureus  (28  cases)  or  Staph
epidermis  (16  cases).  Peritonitis  caused  by  Gram
negative  organisms  was  seen  in  32  cases.  These
comprised Pseudomonas (19 cases), Enterobacter (10
cases) and E.coli (3 cases). Culture from 13 cases of
peritonitis did not reveal any growth. Findings from
other  studies  also  revealed  that  gram-positive
organisms  are  more  responsible  for  causing  most
episodes  of  peritonitis  (64.6%)  than  gram-negative
organisms (20.5%).
29
Table  9:  Frequency  of  organisms  isolated  from
patients peritonitis (n=76)
Organisms Number %
Staphylococcus aureus 28 36.84
Pseudomonas 19 25.00
Staphylococcus Epidemidis 16 21.05
Enterobacter 10 13.16
E.coli 3 3.95
DISUCUSSION
The  effectiveness  of  PD  was  evaluated  in  253
subjects  at the  institute of  Kidney  Diseases,
Peshawar. Kidney failure was more prevalent among
male than in female. This was in agreement with the
finding  of Neugarten  et  al.,  (2000)  that  man
experiences  a  more  rapid  decline  in  renal  function
and worse outcome than in female. The underlying
mechanisms for this gender disparity are potentially
related to differences between the sexes in glomerular
structure, glomerular hemodynamics, diet, variations
in the production and activity of local cytokines and
hormones, and/or the direct effect of sex hormones on
kidney  cells.
10,11 Further  it  is  stated  that  men  with
chronic kidney disease (CKD) are 50% more likely to
progress to renal failure.
129
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The causes of CRF findings suggested that a broader
spectrum  of  CKD  risk  factors  including  both
infectious and  environmental  factors  as  well  as
genetics predisposes to earlier onset and more rapid
progression of CKD. Therefore a basic understanding
of  the  vulnerabilities  will  help  the  treatment  and
prevention of CKD in this population.
13 On the other
hand there is variably among the causes of ARF and
differ from country to country and vary from center
to center in a country. However, there has been an
overall  increase  in  the  incidence  of  ARF  with the
changing etiology of ARF in the recent years. The
incidence of obstetrical, surgical and diarrhea related
ARF have decreased significantly, whereas those of
ARF  associated  with  malaria,  sepsis,  nephrotoxic
drugs and liver diseases have increased.
14
The reason for  using  PD  in  our unit  has  gradually
increased not only in ARF but also in CRF. 60% of
our  patients  who  had  received  PD  had  CRF.  The
usual  form  of  PD  given  to  CRF  patients  is  CAPD
using tencknoff catheter.
15,16 Unfortunately, both the
tenckoff catheter and the CAPD solution are imported
items  making  the  treatment  costly  and  practically
unaffordable for most of our patients. Hence we carry
out  IPD  using  stylet  cannula  and  ordinary  PD
solution.
In  addition  to  financial  restraints  there  are  other
reasons for our increasing use of PD. The majority of
patients  with  CRF  are  usually  illiterate  with  poor
insight and hence generally non-compliant. Suffering
from “denial syndrome” they often consult Hakims
and visit shrines with the hope that their illness will
be cured. Some of the patients belong to the far flung
areas  and  are  unable  to  attend  frequently  for
maintenance HD. Commencing such patients on HD
without  ensuring  HD  its  maintenance  is  of  little
benefit and may, in fact hazardous. For example, HD
often  causes  loss  of  residual  renal  function  and
aggravates oliguria.
17 Oliguria has been implicated as
a poor prognostic factor in ARF and often lead to life
threatening pulmonary edema in CRF.
18,19 A few days
of palliative PD rather than commencing on HD, in
our experience stabilizes such patients and provides
time  for  counseling  and  further  planning  such  as
establishing a permanent vascular access.
Our patients with CRF often face delays in getting a
successful  arterio-venous  fistula.  Dialysis  in  the
meantime is often provided via a temporary vascular
catheter  usually  inserted  into  the  subclavian  vein,
which  often  gets  infected.  This  can  lead  to  life-
threatening  septicemia.
20 It  also  causes  stenosis  or
occlusion  of  the  vein  and  may  lead  to  failure  of
arteio-venous fistula on that side subsequently.
21,22 By
giving  PD  initially,  we  can  prevent  these
complications.
Provided  certain  precautions  are  taken,  insertion  of
the  style  peritoneal  cannula  is  usually  a  safe
procedure.  Perforation  of  the  bowl  is,  however,  a
known  complication  which  usually  responds  to
conservative  treatment.
25,26 None  of  patients  had
either perforation of the bowel or severe hemorrhage.
This was mainly due to our policy of introducing 2 to
3  liters  of  fluid  into  the  peritoneal  cavity  before
cannulation  which  minimizes  the  trauma.  Minor
bleeding occurred in five patients.
Peritonitis curing in 76 patients was the commonest
complication and was mainly due to lack of proper
aseptic condition on part of patient’s relative. Dialysis
was  concluded  when  either  the  required  aims  were
achieved or when peritonitis occurred. With removal
of catheter and antibiotic therapy, peritonitis usually
quickly settled. Pericatheter leak occurred in only five
patients  and  responded  to  reduction  in  volume
exchanges.  Due  to  tremendous  ultra-filtration,
significant  hypovolemia  requiring  the  replacement
fluid  occurred  in  thirteen  patients.  Hypokalemia
occurring in twenty of our cases was treated by the
addition of potassium in the dialysate.
Most our patients accepted PD well. The immediate
aims  of  dialysis  such  as  amelioration  of  uremic
symptoms, correction of acidosis and improvement in
azotemia were achieved in all patients. Fluid overload
was also successfully treated with PD. Fluid removal
facilitated  the  use  of  nutritional fluid.  Some  of the
patients initially treated with PD due to lack of space
in  HD  unit  were  later  shifted  to  HD  when  space
became available and further dialysis required.
CONCLUSION
From our  experience, we  conclude  that  PD  is  an
excellent form of dialysis for the treatment of ARF,
especially  in  children  and  elderly  with
cardiovascular-instability. In addition, it can be used
as an initial treatment in those cases of CRF where
the prospects of  regular  follow-up  for  long-term
dialysis  are  extremely  poor  or  when  there  is
likelihood of delay in getting a permanent vascular
access established.10
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